Paradox of atropine in myopia control: exploring dose-dependent efficacy, rebound effects, and optimal risk-benefit balance–a perspective

Ya-zhen Wu, Yuan-yuan Chen · 2026

Read Paradox of atropine in myopia control: exploring dose-dependent efficacy, rebound effects, and optimal risk-benefit balance–a perspective by Ya-zhen Wu, Yuan-yuan Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13342119.txt.

Description

Atropine eye drops for childhood myopia face an impossible triangle, argue Ya-zhen Wu and Yuan-yuan Chen in a 2026 perspective. Low doses reduce side effects and rebound after stopping, yet may fail to slow eye elongation in the children at highest risk of blinding complications.

The authors propose judging therapy by axial length control, starting age, and environment such as outdoor time rather than refraction alone. A stepped strategy titrating drops alongside optical and behavioral measures is their practical answer. They call for multicentre real-world data with mandatory washout follow-up, aiming at durable blindness prevention instead of temporary prescription stability.

Catalog record

CREATORYa-zhen Wu, Yuan-yuan Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24505
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13342119

Browse the full library · About the Tower of Babel